LifeScience Clinical & Diagnostic
With the help of AI and machine learning models, this collaborative engagement will hopefully lead to the development of more advanced and intelligent solu...
November 06, 2023 | News
Aquinnah Pharmaceuticals announced preclinical research findings for a novel therapeutic designed to slow or stop the progression of Alzheimer's disea...
October 31, 2023 | News
Clario's Precision Motion Opal® wearable sensor technology detects early Parkinson's disease (PD) progression in a Univ...
October 30, 2023 | News
This strategic collaboration combines GC Aesthetics' 40 years’ experience in design, manufacturing, and distribution of Silicone Breast Implants with...
October 27, 2023 | News
The new implants provide orthopaedic surgeons with additional tibial height options for total ankle replacement patients. Both implants are 3D-printed and ...
October 27, 2023 | News
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...
October 26, 2023 | News
PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease and other neurodegenerative diseases...
October 25, 2023 | News
Reaffirming innovation as an AI-based digital microscope while presenting new malaria data at the annual meeting of the ASTMH 2023 Noul's ...
October 24, 2023 | News
In a groundbreaking move, Wellesta Holdings and Ancom Truelife have come together in a pioneering partnership aimed at revolutionizing breast cancer detect...
October 23, 2023 | News
PENBRAYA™ provides the broadest serogroup coverage (meningococcal groups A, B, C, W and Y) of any meningococcal vaccine available in the U.S. ...
October 23, 2023 | News
To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targete...
October 20, 2023 | News
Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow to heal. Such non-healing wounds co...
October 20, 2023 | News
SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with&...
October 19, 2023 | News
Phase 2 is a randomized, double-blind, dose comparison study to evaluate the efficacy, safety and pharmacokinetics of CAN103 in newly treated GD patients, ...
October 17, 2023 | News
Most Read
Bio Jobs
News